What if you'd held ZVRA?
A $1,000 investment in Zevra Therapeutics, Inc. (ZVRA) at the month-end close of 2015-04 would be worth $64.09 at the close of 2026-09 — -93.6% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $4,498.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2015
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2015 | $1,000 | — |
| 2016 | $149 | -85.1% |
| 2017 | $204 | +37.3% |
| 2018 | $89.63 | -56.0% |
| 2019 | $19.07 | -78.7% |
| 2020 | $35.25 | +84.8% |
| 2021 | $27.41 | -22.2% |
| 2022 | $14.44 | -47.3% |
| 2023 | $20.61 | +42.7% |
| 2024 | $26.25 | +27.3% |
| 2025 | $28.20 | +7.4% |
| 2026 | $35.62 | +26.3% |
Best and worst month-end to buy
The best single month-end close to have bought ZVRA was 2020-05 ($3.01): $1,000 then is $3,761 today. The worst was 2015-12 ($318): $1,000 then is $35.62.
FAQ
What would $1,000 in ZVRA be worth today?
A $1,000 investment in Zevra Therapeutics, Inc. (ZVRA) at the start of 2015 would be worth about $64.09 today, a total return of -93.6%. Dividends are reinvested in these figures.
What were the best and worst years for ZVRA?
Zevra Therapeutics, Inc. (ZVRA)'s strongest calendar year since 2015 was 2020, a +84.8% return — $1,000 held through that year became about $1,848 by year-end. Its weakest year was 2016, at -85.1%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in ZVRA have grown?
Investing $100 at the end of every month since 2015-04 would have grown to about $15,277 on $13,800 invested.
Did ZVRA beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $4,498. ZVRA trailed the S&P 500 by +98.6% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Zevra Therapeutics, Inc. (ZVRA) historical total-return data from 2015-04 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-23. Not financial advice.